½ÃÀ庸°í¼­
»óǰÄÚµå
1525106

¼¼°èÀÇ ½ºÅ¸Æ¾ ½ÃÀå(2024-2028³â)

Global statin market 2024-2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechNavio | ÆäÀÌÁö Á¤º¸: ¿µ¹® 151 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ºÅ¸Æ¾ ½ÃÀåÀº 2023-2028³â°£ 26¾ï 2,350¸¸ ´Þ·¯ È®´ëµÇ°í, ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 3.2%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

½ºÅ¸Æ¾ ½ÃÀå¿¡ ´ëÇÑ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ °ÔÀçÇß½À´Ï´Ù.

ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. °íÄÝ·¹½ºÅ×·ÑÇ÷ÁõÀÇ À¯º´·ü »ó½Â, ½ÉÇ÷°üÁúȯ À§Çè¿äÀÎ Áõ°¡, ½ÃÆÇ¾à(OTC)¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼±È£µµ Áõ°¡¿¡ ÀÇÇØ ½ÃÀå ¼ºÀåÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁسâ 2024³â
Á¾·á³â 2028³â
¿¹Ãø ±â°£ 2024-2028³â
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
YOY 2024 3.06%
CAGR 3.2%
ÁõºÐ¾× 26¾ï 2,350¸¸ ´Þ·¯

º» Á¶»ç¿¡¼­´Â ÇâÈÄ ¸î ³â°£ ½ºÅ¸Æ¾ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿äÀÎ Áß Çϳª·Î¼­ °ü»óµ¿¸Æ Áúȯ(CHD)ÀÇ ³ôÀº ÀÌȯÀ²À» µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼ÒºñÀÚÀÇ °Ç°­ÁöÇâ Áõ°¡¿Í ¼±Áø Áö¿ª¿¡¼­ÀÇ ÁÂ½Ä ¶óÀÌÇÁ½ºÅ¸ÀÏÀº ½ÃÀåÀÇ Å« ¼ö¿ä·Î ¿¬°áµÉ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä

Á¦2Àå ½ÃÀå ±¸µµ

  • ½ÃÀå »ýŰè
  • ½ÃÀå Æ¯Â¡
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦3Àå ½ÃÀå ±Ô¸ð Æò°¡

  • ½ÃÀåÀÇ Á¤ÀÇ
  • ½ÃÀå ºÎ¹® ºÐ¼®
  • ½ÃÀå ±Ô¸ð(2023³â)
  • ½ÃÀå Àü¸Á(2023-2028³â)

Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû

  • ¼¼°èÀÇ ½ºÅ¸Æ¾ ½ÃÀå(2018-2022³â)
  • ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® ºÐ¼®(2018-2022³â)
  • À¯Çüº° ºÎ¹® ºÐ¼®(2018-2022³â)
  • Áö¿ªº° ºÎ¹® ºÐ¼®(2018-2022³â)
  • ±¹°¡º° ºÎ¹® ºÐ¼®(2018-2022³â)

Á¦5Àå Five Forces ºÐ¼®

  • Five Forces ¿ä¾à
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù
  • °æÀï À§Çù
  • ½ÃÀå ÇöȲ

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ¼¼ºÐÈ­
  • ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
  • º´¿ø : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • Ŭ¸®´Ð : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°

Á¦7Àå ½ÃÀå ¼¼ºÐÈ­ : À¯Çüº°

  • ½ÃÀå ¼¼ºÐÈ­
  • ºñ±³ : À¯Çüº°
  • ÇÕ¼º ½ºÅ¸Æ¾ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • õ¿¬ ½ºÅ¸Æ¾ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ½ÃÀå ±âȸ : À¯Çüº°

Á¦8Àå °í°´ »óȲ

  • °í°´ »óȲ °³¿ä

Á¦9Àå Áö¿ªº° »óȲ

  • Áö¿ªº° ¼¼ºÐÈ­
  • Áö¿ªº° ºñ±³
  • ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ½ÃÀå ±âȸ : Áö¿ª »óȲº°

Á¦10Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¾ïÁ¦¿äÀÎ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
  • ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
  • ½ÃÀå ±âȸ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦11Àå °æÀï ±¸µµ

  • °³¿ä
  • °æÀï ±¸µµ
  • È¥¶õ »óȲ
  • ¾÷°è ¸®½ºÅ©

Á¦12Àå °æÀï ºÐ¼®

  • ±â¾÷ °³¿ä
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
  • Abbott Laboratories
  • Amgen Inc.
  • AstraZeneca Plc
  • Aurobindo Pharma Ltd.
  • Biocon Ltd.
  • Concord Biotech Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Thermo Fisher Scientific Inc.

Á¦13Àå ºÎ·Ï

LSH 24.08.14

The statin market is forecasted to grow by USD 2623.5 mn during 2023-2028, accelerating at a CAGR of 3.2% during the forecast period. The report on the statin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of hypercholesterolemia, increasing risk factors for cardiovascular diseases, and increasing consumer preference for over-the-counter (otc) drugs.

Technavio's statin market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20243.06%
CAGR3.2%
Incremental Value$2623.5mn

By End-user

  • Hospitals
  • Clinics
  • Others

By Type

  • Synthetic statin
  • Natural statin

By Geographical Landscape

  • North America
  • Asia
  • Europe
  • Rest of World (ROW)

This study identifies the strong incidence of chd as one of the prime reasons driving the statin market growth during the next few years. Also, growing health consciousness among consumers and sedentary lifestyle across the developed regions will lead to sizable demand in the market.

The report on the statin market covers the following areas:

  • Statin market sizing
  • Statin market forecast
  • Statin market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading statin market vendors that include Abbott Laboratories, Amgen Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Biocon Ltd., Concord Biotech Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Thermo Fisher Scientific Inc.. Also, the statin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Statin Market 2018 - 2022
    • Historic Market Size - Data Table on Global Statin Market 2018 - 2022 ($ million)
  • 4.2 End-user segment analysis 2018 - 2022
    • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • 4.3 Type segment analysis 2018 - 2022
    • Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

  • 6.1 Market segments
    • Chart on End-user - Market share 2023-2028 (%)
    • Data Table on End-user - Market share 2023-2028 (%)
  • 6.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 6.3 Hospitals - Market size and forecast 2023-2028
    • Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
    • Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
    • Chart on Hospitals - Year-over-year growth 2023-2028 (%)
    • Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • 6.4 Clinics - Market size and forecast 2023-2028
    • Chart on Clinics - Market size and forecast 2023-2028 ($ million)
    • Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
    • Chart on Clinics - Year-over-year growth 2023-2028 (%)
    • Data Table on Clinics - Year-over-year growth 2023-2028 (%)
  • 6.5 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ million)
    • Data Table on Others - Market size and forecast 2023-2028 ($ million)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 6.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

  • 7.1 Market segments
    • Chart on Type - Market share 2023-2028 (%)
    • Data Table on Type - Market share 2023-2028 (%)
  • 7.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 7.3 Synthetic statin - Market size and forecast 2023-2028
    • Chart on Synthetic statin - Market size and forecast 2023-2028 ($ million)
    • Data Table on Synthetic statin - Market size and forecast 2023-2028 ($ million)
    • Chart on Synthetic statin - Year-over-year growth 2023-2028 (%)
    • Data Table on Synthetic statin - Year-over-year growth 2023-2028 (%)
  • 7.4 Natural statin - Market size and forecast 2023-2028
    • Chart on Natural statin - Market size and forecast 2023-2028 ($ million)
    • Data Table on Natural statin - Market size and forecast 2023-2028 ($ million)
    • Chart on Natural statin - Year-over-year growth 2023-2028 (%)
    • Data Table on Natural statin - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.5 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.9 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.10 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ million)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 9.11 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
  • 12.4 Amgen Inc.
    • Amgen Inc. - Overview
    • Amgen Inc. - Product / Service
    • Amgen Inc. - Key news
    • Amgen Inc. - Key offerings
  • 12.5 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
  • 12.6 Aurobindo Pharma Ltd.
    • Aurobindo Pharma Ltd. - Overview
    • Aurobindo Pharma Ltd. - Product / Service
    • Aurobindo Pharma Ltd. - Key offerings
  • 12.7 Biocon Ltd.
    • Biocon Ltd. - Overview
    • Biocon Ltd. - Business segments
    • Biocon Ltd. - Key offerings
    • Biocon Ltd. - Segment focus
  • 12.8 Concord Biotech Ltd.
    • Concord Biotech Ltd. - Overview
    • Concord Biotech Ltd. - Product / Service
    • Concord Biotech Ltd. - Key offerings
  • 12.9 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
  • 12.10 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
  • 12.11 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
  • 12.12 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦